Chartwell Molecules Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHARTWELL MOLECULES, and what generic and branded alternatives to CHARTWELL MOLECULES drugs are available?
CHARTWELL MOLECULES has twenty-one approved drugs.
Drugs and US Patents for Chartwell Molecules
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Molecules | ONDANSETRON | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 077406-001 | Dec 26, 2006 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Chartwell Molecules | SULFAMETHOXAZOLE AND TRIMETHOPRIM | sulfamethoxazole; trimethoprim | TABLET;ORAL | 078060-001 | Jan 25, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Molecules | ONDANSETRON | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 077406-004 | Dec 26, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Molecules | INDOMETHACIN | indomethacin | CAPSULE;ORAL | 018829-001 | Aug 6, 1984 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Molecules | ONDANSETRON | ondansetron | TABLET, ORALLY DISINTEGRATING;ORAL | 077406-003 | Dec 26, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Molecules | ETODOLAC | etodolac | CAPSULE;ORAL | 074842-001 | Jul 17, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.